Author:
Xavier Elizabeth S,Nair Vishnu R,Shajahan Shahanas P,Raheem Abdul,Philips Geetha,Valsalan Praveen,Pradeep Manu
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Therapeutics and COVID- 19. living guideline. (2022). Accessed: October 25, 2023: https://www.who.int/publications/i/item/WHO-2019-nCoV-therapeutics-2022.4.
2. Modelling the first wave of COVID-19 in India;Hazra DK;PLoS Comput Biol,2022
3. Clinical management protocol for COVID-19 - COVID-19 guideline committee. (2020). Accessed. November 14, 2023: https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf.
4. Safety and clinical outcomes of remdesivir in hospitalised COVID-19 patients: a retrospective analysis of active surveillance database;Gupte V;BMC Infect Dis,2022
5. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro;Wang M;Cell Res,2020